Financial results - ANA-PHARM SRL

Financial Summary - Ana-Pharm Srl
Unique identification code: 10150315
Registration number: J1998000054224
Nace: 4773
Sales - Ron
1.397.387
Net Profit - Ron
26.620
Employees
21
Open Account
Company Ana-Pharm Srl with Fiscal Code 10150315 recorded a turnover of 2024 of 1.397.387, with a net profit of 26.620 and having an average number of employees of 21. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Ana-Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.257.454 1.128.901 1.273.707 1.383.607 1.354.060 1.441.025 1.416.514 1.561.471 1.855.190 1.397.387
Total Income - EUR 1.257.466 1.128.901 1.276.147 1.387.282 1.355.851 1.442.374 1.421.690 1.572.454 1.858.839 1.409.870
Total Expenses - EUR 1.208.640 1.089.336 1.202.054 1.298.885 1.282.407 1.360.391 1.393.271 1.539.154 1.835.484 1.378.180
Gross Profit/Loss - EUR 48.826 39.566 74.093 88.397 73.444 81.983 28.420 33.300 23.354 31.690
Net Profit/Loss - EUR 36.387 31.612 61.349 73.978 60.716 72.585 24.169 27.663 20.210 26.620
Employees 23 27 25 24 24 27 21 23 22 21
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -24.3%, from 1.855.190 euro in the year 2023, to 1.397.387 euro in 2024. The Net Profit increased by 6.523 euro, from 20.210 euro in 2023, to 26.620 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Ana-Pharm Srl

Rating financiar

Financial Rating -
ANA-PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Ana-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ana-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Ana-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ana-Pharm Srl - CUI 10150315

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 84.506 85.154 79.213 75.255 78.489 71.202 81.091 75.636 69.162 62.565
Current Assets 308.506 278.585 391.811 405.055 432.193 523.451 345.700 377.625 303.180 324.077
Inventories 194.587 190.178 216.812 176.890 282.291 326.859 151.918 160.630 163.640 144.054
Receivables 84.091 40.097 147.404 207.539 178.876 230.278 179.544 209.928 124.500 177.148
Cash 29.827 48.310 27.595 20.626 -28.975 -33.686 14.237 7.067 15.040 2.875
Shareholders Funds 74.017 43.679 67.522 104.757 109.745 124.757 50.955 56.177 59.779 65.524
Social Capital 67 67 66 64 63 62 61 61 61 60
Debts 318.994 320.060 403.503 375.553 400.937 469.896 454.377 461.358 341.791 387.627
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 324.077 euro in 2024 which includes Inventories of 144.054 euro, Receivables of 177.148 euro and cash availability of 2.875 euro.
The company's Equity was valued at 65.524 euro, while total Liabilities amounted to 387.627 euro. Equity increased by 6.079 euro, from 59.779 euro in 2023, to 65.524 in 2024.

Risk Reports Prices

Reviews - Ana-Pharm Srl

Comments - Ana-Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.